184 related articles for article (PubMed ID: 33978906)
1. One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS).
Chan JCN; Gagliardino JJ; Ilkova H; Lavalle F; Ramachandran A; Mbanya JC; Shestakova M; Dessapt-Baradez C; Chantelot JM; Aschner P
Adv Ther; 2021 Jun; 38(6):3281-3298. PubMed ID: 33978906
[TBL] [Abstract][Full Text] [Related]
2. Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).
Aschner P; Gagliardino JJ; Ilkova H; Lavalle F; Ramachandran A; Mbanya JC; Shestakova M; Chantelot JM; Chan JCN
Diabetologia; 2020 Apr; 63(4):711-721. PubMed ID: 31901950
[TBL] [Abstract][Full Text] [Related]
3. Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study.
Sreenan S; Virkamäki A; Zhang K; Hansen JB;
Int J Clin Pract; 2008 Dec; 62(12):1971-80. PubMed ID: 19166444
[TBL] [Abstract][Full Text] [Related]
4. [Hypoglycaemia in patients with type 1 and type 2 diabetes mellitus on insulin therapy. Results of the global HAT study in Argentina].
Costa Gil JE; Linari MA; Pugnaloni N; Zambon FG; Pérez Manghi F; Rezzónico M;
Medicina (B Aires); 2017; 77(6):449-457. PubMed ID: 29223934
[TBL] [Abstract][Full Text] [Related]
5. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies.
Pedersen-Bjergaard U; Alsifri S; Aronson R; Berković MC; Galstyan G; Gydesen H; Lekdorf JB; Ludvik B; Moberg E; Ramachandran A; Khunti K
Diabetes Obes Metab; 2019 Apr; 21(4):844-853. PubMed ID: 30456887
[TBL] [Abstract][Full Text] [Related]
7. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
[TBL] [Abstract][Full Text] [Related]
8. Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria.
Bohn B; Kerner W; Seufert J; Kempe HP; Jehle PM; Best F; Füchtenbusch M; Knauerhase A; Hofer M; Rosenbauer J; Holl RW;
Diabetes Res Clin Pract; 2016 May; 115():31-8. PubMed ID: 27242120
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.
Mathiesen ER; Ali N; Anastasiou E; Cypryk K; de Valk HW; Dores JM; Dunne FP; Ekelund M; Durán García S; Hanaire H; Husemoen LLN; Ivanisevic M; Kempe HP; Nordsborg RB; McCance DR
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7992-8000. PubMed ID: 34182866
[TBL] [Abstract][Full Text] [Related]
10. The Rate of Insulin use and Suboptimal Glycemic Control among Egyptian Patients with T2DM: Cohort Analysis of Eighth Wave of the International Diabetes Management Practices Study (IDMPS).
Khalil SHA; Khaled M; Zakhary R; Shereen M
Curr Diabetes Rev; 2024; 20(3):e020623217590. PubMed ID: 37264625
[TBL] [Abstract][Full Text] [Related]
11. Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
DeVries JH; Bailey TS; Bhargava A; Gerety G; Gumprecht J; Heller S; Lane W; Wysham CH; Zinman B; Bak BA; Hachmann-Nielsen E; Philis-Tsimikas A
Diabetes Obes Metab; 2019 Mar; 21(3):622-630. PubMed ID: 30362250
[TBL] [Abstract][Full Text] [Related]
12. Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes.
Aronson R; Galstyan G; Goldfracht M; Al Sifri S; Elliott L; Khunti K
Diabetes Res Clin Pract; 2018 Apr; 138():35-43. PubMed ID: 29355651
[TBL] [Abstract][Full Text] [Related]
13. Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers.
Jendle J; Reznik Y
Diabetes Obes Metab; 2023 Jul; 25 Suppl 2():21-32. PubMed ID: 37046364
[TBL] [Abstract][Full Text] [Related]
14. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
15. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
Diabetes Obes Metab; 2016 Sep; 18(9):907-15. PubMed ID: 27161418
[TBL] [Abstract][Full Text] [Related]
16. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
17. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
[TBL] [Abstract][Full Text] [Related]
18. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
19. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
